Status:
RECRUITING
Japanese CTO PCI Expert Registry
Lead Sponsor:
Kurashiki Central Hospital
Collaborating Sponsors:
Japanese CTO PCI Expert Registry investigators
Conditions:
Chronic Total Occlusion of Coronary Artery
Eligibility:
All Genders
20+ years
Brief Summary
The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO perfor...
Eligibility Criteria
Inclusion
- Patients eligible for PCI
- Patients who underwent PCI for CTO lesions that contain the following:
- Thrombolysis in myocardial infarction trial (TIMI) 0
- The occlusive period more than 3 months or unknown
- The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9/10, 12) and graft
Exclusion
- Patients ineligible for PCI judged in clinical practice
Key Trial Info
Start Date :
July 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
19000 Patients enrolled
Trial Details
Trial ID
NCT01889459
Start Date
July 1 2013
End Date
December 1 2027
Last Update
July 2 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Kurashiki Central Hospital
Kurashiki, Japan, 710-8602